The RAPS website recently experienced issues that we continue to monitor.  Certain areas of the site including news may be limited.  We apologize for any inconvenience.

Regulatory Focus

FDA finalizes guidances on complex generics meetings, drug development tools

25 November 2020 | By Kari Oakes

The US Food and Drug Administration (FDA) has finalized guidance for industry on the pathway for discussions about complex products....

Regulatory Exchange